Reply
Tammy T. Chang – 27 December 2016
Instructions to authors and Information for readers
27 December 2016
Reply
Jenny Yeuk‐Ki Cheng, Yee‐Kit Tse, Grace Lai‐Hung Wong – 23 December 2016
Effect of metabolic syndrome on cardiovascular, hepatic events, and death in chronic hepatitis B patients: Methodological issues
Erfan Ayubi, Saeid Safiri, Mohadeseh Sani, Amin Doosti‐Irani, Ali Sanjari Moghaddam – 23 December 2016
Reply:
Gordon D. McLaren, James C. Barton, Grant A. Ramm, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, Paul C. Adams, Lawrie W. Powell, Lyle C. Gurrin, Gregory J. Anderson, Christine E. McLaren – 23 December 2016
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention
Giovanni Brandi, Stefania De Lorenzo, Andrea Palloni, Guido Biasco, Francesco Tovoli – 23 December 2016
Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit
Umberto Cillo, Alessandro Vitale, Marina Polacco, Elisa Fasolo – 23 December 2016
Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients
Beatriz Revilla‐Nuin, África de Bejar, Laura Martínez‐Alarcón, José Ignacio Herrero, Carlos Manuel Martínez‐Cáceres, Pablo Ramírez, Alberto Baroja‐Mazo, José Antonio Pons – 22 December 2016 – Regulatory T cells (Tregs) play a potential role in operational tolerance in liver transplantation (LT) patients, and microRNAs (miRNAs) are known to be involved in immunological responses and tolerance.
Liver splitting during normothermic organ preservation
Jens G. Brockmann, Thomas Vogel, Constantin Coussios, Peter J. Friend – 22 December 2016
Current status of auxiliary partial orthotopic liver transplantation for acute liver failure
Henri Bismuth – 22 December 2016